tiprankstipranks
Oragenics Inc (OGEN)
NYSE MKT:OGEN
Holding OGEN?
Track your performance easily

Oragenics (OGEN) Stock Price & Analysis

983 Followers

OGEN Stock Chart & Stats


Financials

Annual

Ownership Overview

1.45%0.38%0.58%97.51%
0.58% Other Institutional Investors
97.51% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

OGEN FAQ

What was Oragenics Inc’s price range in the past 12 months?
Oragenics Inc lowest stock price was $0.25 and its highest was $7.74 in the past 12 months.
    What is Oragenics Inc’s market cap?
    Currently, no data Available
    When is Oragenics Inc’s upcoming earnings report date?
    Oragenics Inc’s upcoming earnings report date is Aug 12, 2024 which is 136 days ago.
      How were Oragenics Inc’s earnings last quarter?
      Oragenics Inc released its earnings results on May 13, 2024. The company reported -$0.701 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.701.
        Is Oragenics Inc overvalued?
        According to Wall Street analysts Oragenics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Oragenics Inc pay dividends?
          Oragenics Inc does not currently pay dividends.
          What is Oragenics Inc’s EPS estimate?
          Oragenics Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Oragenics Inc have?
          Oragenics Inc has 12,212,680 shares outstanding.
            What happened to Oragenics Inc’s price movement after its last earnings report?
            Oragenics Inc reported an EPS of -$0.701 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 48.571%.
              Which hedge fund is a major shareholder of Oragenics Inc?
              Currently, no hedge funds are holding shares in OGEN
              ---

              Company Description

              Oragenics Inc

              Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Advaxis
              Aclaris Therapeutics
              PAVmed
              Citius Pharmaceuticals
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis